Local recurrence after breast conserving therapy for invasive breast cancer: Analysis of prognostic factors

Clinical and Translational Oncology

Volumn 5, Issue 2, 2003, Pages 93-97

  Medina Franco, Heriberto ^a   Beenken, Samuel W ^b   Heslin, Martin J ^b   Salter, Merle ^c   Urist, Marshall M ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Sección de Cirugía Oncológica   (Poland)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Breast cancer; Breast conservation therapy; Local recurrence; Radiation therapy

Indexed keywords

EID: 49749101846     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Clark RM, Wilkinson RH, Mahoney LJ, et al. Breast cancer: a 21 year experience with conservative surgery and radiation. Int J Radiat Oncol Biol Phys 1982;8:967-75.
2. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Eng J Med 1995;333:1456-61.
3. Veronesi U, Luini A, Galimberti V, et al. Conservation approaches for the management of Stage I/II carcinoma of the breast: Milan Cancer Institute Trials. World J Surg 1994;18:70-5.
4. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1668-75.
5. Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Eng J Med 1996;334:1356-61.
6. Kurtz JM, Jacquemier J, Amarlic R. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990;65:1867-78.
7. Clarke DH, Le MG, Sarrazin D. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985;11: 137-45.
8. Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12:888-94.
9. Fisher B, Constantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989; 320:479-84.
10. American Cancer Society. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 5th edition. Lippincott-Raven, 1997.
11. Blichert-Taft M, Rose C, Andersen JA, et al. Danish Randomized trial comparing breast conservation therapy with mastectomy: six-years of life table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1991;11:19-25.
12. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. J Clin Oncol 1992; 10:976-83.
13. Sarrazin D, Le MG, Arrigada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989;14:177-84.
14. Van Dongen JA, Bartelink H, Fentimen JS, et al. Randomized trial to asses the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 1992;11:15-8.
15. Kurtz J, Jacqemier J, Amarlic R, et al. Why are local recurrences after breast conserving therapy more frequent in younger patients? J Clin Oncol 1990;8:591-8.
16. De la Rochefordiere A, Asselain B, Campana F et al. Age as a prognostic factor in premenopausal breast carcinoma. Lancet 1993;341:1039-43.